Updated regularly with industry analysts, clinical comiderations, and operational best practices

What is peptide sourcing and compounding?

Peptide sourcing and compounding refers to the regulated process of manufacturing, distributing and fulfilling peptide products through licensed 503A pharmacies and FDA registered 5038 outsourcing facilities for clinical and research use.

Beyond Compliance: The Hospital Administrator's Guide to Vetting a 503B Outsourcing Facility for Risk-Free Fulfillment
Hospital & Health Systems

Beyond Compliance: The Hospital Administrator's Guide to Vetting a 503B Outsourcing Facility for Risk-Free Fulfillment

December 18, 2025 · 10 min read min read

Hospitals vet 503B outsourcing facilities by verifying FDA registration and inspection history, r...

Read More →
A Beginner's Guide to the Peptide Industry: Sourcing, Compliance, and Distribution Explained
Industry Education

A Beginner's Guide to the Peptide Industry: Sourcing, Compliance, and Distribution Explained

December 18, 2025 · 10 min read min read

The peptide industry has grown rapidly, but for newcomers, it can feel opaque and overly technica...

Read More →
How 503A Pharmacies Can Expand Revenue and Reduce Risk Through Strategic 503B Partnerships
Pharmacy Operations

How 503A Pharmacies Can Expand Revenue and Reduce Risk Through Strategic 503B Partnerships

December 18, 2025 · 8 min read min read

A 503A–503B partnership is a strategic alignment where independent 503A compounding pharmacies co...

Read More →
503A vs 503B: Understanding the Differences Between Compounding Pathways
Regulatory

503A vs 503B: Understanding the Differences Between Compounding Pathways

December 09, 2025 · 15 min read min read

The terms 503A and 503B are frequently referenced in pharmaceutical compounding, but understandin...

Read More →
How to Build a Compliant and Scalable Peptide Program for Your Medical or Wellness Practice
Business

How to Build a Compliant and Scalable Peptide Program for Your Medical or Wellness Practice

December 09, 2025 · 12 min read min read

Peptide therapy has become a rapidly growing offering across medical clinics and wellness practic...

Read More →
Peptides Beyond GLPs: Emerging Therapies Clinics Are Adopting Today
Clinical

Peptides Beyond GLPs: Emerging Therapies Clinics Are Adopting Today

December 18, 2025 · 13 min read min read

As uncertainty continues to surround GLP-1 therapies, many clinics and telemedicine providers are...

Read More →
AI, Telemedicine, and the Future of Cost-Effective Personalized Medicine
Industry Insights

AI, Telemedicine, and the Future of Cost-Effective Personalized Medicine

December 18, 2025 · 14 min read min read

Artificial intelligence is no longer a future concept in healthcare. It is already reshaping how ...

Read More →
Why Telemedicine Is Set to Overtake Brick-and-Mortar Healthcare by 2030
Industry Insights

Why Telemedicine Is Set to Overtake Brick-and-Mortar Healthcare by 2030

December 18, 2025 · 16 min read min read

Telemedicine has moved far beyond a temporary solution introduced during the COVID-19 pandemic. I...

Read More →
How Clinics and Telemedicine Providers Can Future-Proof Peptide Programs Amid Regulatory Change
Industry Insights

How Clinics and Telemedicine Providers Can Future-Proof Peptide Programs Amid Regulatory Change

December 16, 2025 · 9 min read min read

Peptide therapy has become one of the fastest-growing service lines across medical clinics, telem...

Read More →
The Future of Research Peptides: Regulatory Trends, What's Changing, and How to Prepare
Trends

The Future of Research Peptides: Regulatory Trends, What's Changing, and How to Prepare

December 18, 2025 · 14 min read min read

Research peptides remain a large and fast moving market, but the operating environment is becomin...

Read More →
The Future of Peptide Therapy in Telemedicine
Trends

The Future of Peptide Therapy in Telemedicine

December 09, 2025 · 12 min read min read

Telemedicine has transformed how patients access preventative and specialty care. As virtual care...

Read More →